Asante Solutions announced that it is ceasing all business operations and will no longer sell or support the Asante Snap Insulin Pump. This means all current Asante Snap Insulin Pump users will soon need to transition to a new insulin pump.
Category: Products & Tech
The U.S. Food and Drug Administration (FDA) approved Becton Dickinson Medical's (BD) application to begin production of its novel FlowSmart insulin infusion set, designed to improve insulin delivery with less pain. The FlowSmart insulin infusion set was developed in collaboration with JDRF and the Helmsley Charitable Trust.
The European Commission has granted Sanofi marketing authorization in Europe for Toujeo (insulin glargine [rDNA origin] injection, 300 U/mL), for the treatment of type 1 and type 2 diabetes mellitus in adults. Toujeo is a next-generation, once-daily basal insulin based on a broadly-used molecule (insulin glargine) with a well-established benefit-risk profile.
The school was there to figure out a way to help my daughter embrace pumping without having to leave the classroom to go to the nurse a bunch of times a day. Together we eventually came up with a plan that worked, but it didn’t happen overnight. It took time, and it also required me to understand the school’s needs, point of view and accept how they might need to come up short of what my expectations at home would be.
With the Dexcom Share usage sweeping the diabetes community, my adult daughter with diabetes and I decided to experiment. She – the person with diabetes- would get one and let me look in on her life with diabetes for a while. She’d see what it was like – after all these years of independence – to have someone oversee her diabetes life. I – the parent of someone with diabetes—would see – after years of trusting her and supporting her from afar – if I could handle seeing how life goes for her minute by minute.
When you’re living with the everyday ups and downs of blood glucose and medication levels, it can be easy to focus on the immediate consequences of your management efforts – and eventually lose sight of the big blood sugar picture.
Researchers at MIT successfully tested an engineered “smart insulin” on mice that reacts to blood sugar levels.
“To make insulin that is…
The U.S. Food and Drug Administration (FDA) approved Sanofi’s new once daily long acting insulin, Toujeo (insulin glargine [rDNA origin] injection, 300 U/mL) for treatment of adults living with type 1 and type 2 diabetes.
Toujeo will be available in the Toujeo SoloSTAR, a disposable prefilled pen which contains 450 units of Toujeo and requires one third of the injection volume to deliver the same number of insulin units as compared to the Lantus SoloSTAR.
The U.S. Food and Drug Administration (FDA) has approved Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Company’s Glyxambi for treatment of adults with type 2 diabetes.
Glyxambi is the first and only diabetes treatment in the U.S. to combine the dual mechanisms of ....
Medtronic, Inc. announced the global launch of the MiniMed 640G System, the next breakthrough toward an artificial pancreas.
The system is the first in the world to both automatically suspend insulin delivery when sensor glucose levels are predicted to approach a low limit, and then resume insulin delivery once sensor glucose levels recover.